Insulet Corporation (PODD)
NASDAQ·Healthcare·Medical - Devices
$182.95
-2.85%
Mkt Cap $13.54B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 18, 2026 | $768.97M | $783.80M | +1.93% | $1.47 | $1.55 | +5.44% | — | — |
| Q4 2025 Nov 6, 2025 | $678.41M | $706.30M | +4.11% | $1.14 | $1.24 | +8.77% | — | — |
| Q3 2025 Aug 7, 2025 | $614.20M | $649.10M | +5.68% | $0.92 | $1.17 | +27.17% | — | — |
| Q2 2025 May 8, 2025 | $543.29M | $569.00M | +4.73% | $0.79 | $1.02 | +29.11% | — | — |
| Q1 2025 Feb 20, 2025 | $582.54M | $597.50M | +2.57% | $1.00 | $1.15 | +15.00% | — | — |
| Q4 2024 Nov 7, 2024 | $519.51M | $372.60M | -28.28% | $0.76 | $0.90 | +18.42% | — | — |
| Q3 2024 Aug 8, 2024 | $488.00M | $488.50M | +0.10% | $0.56 | $0.55 | -2.48% | — | — |
| Q2 2024 May 9, 2024 | $424.05M | $441.70M | +4.16% | $0.39 | $0.73 | +87.18% | — | — |
| Q1 2024 Feb 22, 2024 | $461.05M | $509.80M | +10.57% | $0.66 | $1.40 | +112.12% | — | — |
| Q4 2023 Nov 2, 2023 | $414.38M | $432.70M | +4.42% | $0.40 | $0.71 | +77.50% | — | — |
| Q3 2023 Aug 8, 2023 | $384.95M | $396.50M | +3.00% | $0.26 | $0.38 | +46.15% | — | — |
| Q2 2023 May 4, 2023 | $330.84M | $358.10M | +8.24% | $0.09 | $0.23 | +155.56% | — | — |
| Q1 2023 Feb 23, 2023 | $332.45M | $369.70M | +11.21% | $0.24 | $0.55 | +129.17% | — | — |
| Q4 2022 Nov 3, 2022 | $312.11M | $340.80M | +9.19% | $0.17 | $0.45 | +164.71% | — | — |
| Q3 2022 Aug 4, 2022 | $291.45M | $299.40M | +2.73% | $0.21 | -$0.06 | -128.57% | — | — |
| Q2 2022 May 5, 2022 | $288.02M | $295.40M | +2.56% | $0.23 | $0.40 | +73.91% | — | — |
| Q1 2022 Feb 23, 2022 | $299.33M | $307.70M | +2.79% | $0.32 | $0.42 | +31.25% | — | — |
| Q4 2021 Nov 4, 2021 | $272.82M | $275.60M | +1.02% | $0.24 | $0.18 | -25.00% | — | — |
| Q3 2021 Aug 5, 2021 | $259.08M | $263.20M | +1.59% | $0.12 | $0.10 | -16.67% | — | — |
| Q2 2021 May 6, 2021 | $246.22M | $252.30M | +2.47% | $0.07 | $0.01 | -87.03% | — | — |